USE OF SODIUM TETRADECYL SULFATE IN THE TREATMENT OF PATIENTS WITH VENOUS MALFORMATIONS OF THE MAXILLOFACIAL REGION

The aim of the study was to evaluate the effectiveness of the foam form of 3% sodium tetradecyl sulfate in the treatment of patients with venous malformations of the maxillofacial region. The study included 30 patients with venous malformations of the maxillofacial region. The patients were divided into three groups: group 1 – patients with a small malformations size up to 2cm in diameter; group 2 – patients with an average malformations size from 2 to 6cm in diameter; group 3 – patients with a large malformations size from 6cm in diameter. In the treatment of patients, a foam form of 3% sodium tetradecyl sulfate was used. All patients were treated without intraoperative and postoperative bleeding. According to the results of the study, large malformations decreased in size by an average of 49.7%, medium malformations decreased by an average of 68.1%, while small malformations decreased by 69.6%. Sclerosing of venous malformations of the maxillofacial region with a foam form of 3% sodium tetradecyl sulfate is an effective, easily accessible and safe treatment method.